360Dx Highlights bioMérieux’s Development of Advanced Analytics to Support Hospitals’ Antimicrobial Stewardship Initiatives
Asia
Europe, Middle East, Africa
North America
bioMérieux in the Press: 360Dx
22 August, 2019
Independence Day Shipping Schedule
04 July, 2019
Please be advised that bioMérieux, Inc. sites in Durham, NC, St. Louis, MO, Louisville, KY, and Lombard, IL will be closed on Thursday, July 4th, 2019 in observance of Independence Day. We encourage you to place orders with the following dates in mind.
Memorial Day Shipping Schedule
20 May, 2019
Please be advised that bioMérieux, Inc. sites in Durham, NC, St. Louis, MO, Louisville, KY, and Lombard, IL will be closed on Monday, May 27, 2019 in observance of the Memorial Day holiday. We encourage you to place orders with the following dates in mind.
NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in the ERAS “Guidelines for Perioperative Care in Cardiac Surgery”
14 May, 2019
The NEPHROCHECK® Test biomarkers (TIMP- 2 and IGFBP7) that indicate kidney stress in advance of acute kidney injury (AKI) have been included in the “Guidelines for Perioperative Care in Cardiac Surgery” which were published by the ERAS® (Enhanced Recovery After Surgery) Cardiac Society, an international group of leading heart surgeons, anesthesiologists and critical care specialists.
bioMérieux – First-Quarter 2019 Business Review
24 April, 2019
Marcy l'Étoile, April 24, 2019 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2019.
Holiday Shipping Schedule
15 April, 2019
Please be advised that bioMérieux, Inc. sites in Durham, NC, St. Louis, MO, Louisville, KY, and Lombard, IL will be closed on Friday, April 19, 2019 in observance of the upcoming holiday. We encourage you to place orders with these dates in mind.
University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics
02 April, 2019
The University of Antwerp, bioMérieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicines Initiative (IMI) project initiated by six in vitro diagnostic companies who join forces with 20 non-industry partners to combat antimicrobial resistance (AMR) and improve patient outcomes.
Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury
19 March, 2019
Baxter International Inc., a global leader in acute care, and bioMérieux, a world leader in the field of in vitro diagnostics, announced an agreement to develop future biomarkers with the goal to rapidly identify and inform treatment of acute kidney injury (AKI).
bioMérieux acquires Invisible Sentinel, a US-based company specialized in food and beverage molecular testing
07 February, 2019
bioMérieux, a global player in in vitro diagnostics and world leader in food microbiology testing, today announced the acquisition of Invisible Sentinel Inc.
Holiday Shipping Schedule
17 January, 2019
Please be advised that bioMérieux Inc. sites in Durham, NC, St. Louis, MO, Louisville, KY, and Lombard, IL will be closed on Monday, January 21, 2019 in observance of Martin Luther King Jr. Day.